BlackRock Institutional Trust’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.41M	Buy	2,344,623 +72,761	+3%	+$223K	﹤0.01%	2575
2016 Q3	$7.75M	Buy	2,271,862 +68,023	+3%	+$188K	﹤0.01%	2490
2016 Q2	$5.03M	Buy	2,203,839 +18,784	+0.9%	+$46.1K	﹤0.01%	2679
2016 Q1	$5.49M	Sell	2,185,055 -190,599	-8%	-$425K	﹤0.01%	2607
2015 Q4	$7.86M	Buy	2,375,654 +103,515	+5%	+$309K	﹤0.01%	2482
2015 Q3	$5.5M	Sell	2,272,139 -87,510	-4%	-$227K	﹤0.01%	2662
2015 Q2	$6.91M	Sell	2,359,649 -8,555	-0.4%	-$33.2K	﹤0.01%	2606
2015 Q1	$9.5M	Buy	2,368,204 +63,274	+3%	+$219K	﹤0.01%	2418
2014 Q4	$6.94M	Buy	2,304,930 +1,011	+0%	+$2.73K	﹤0.01%	2566
2014 Q3	$5.84M	Buy	2,303,919 +120,133	+6%	+$289K	﹤0.01%	2617
2014 Q2	$5.38M	Buy	2,183,786 +126,595	+6%	+$286K	﹤0.01%	2752
2014 Q1	$5.46M	Buy	2,057,191 +267,451	+15%	+$787K	﹤0.01%	2746
2013 Q4	$5.2M	Buy	1,789,740 +152,790	+9%	+$462K	﹤0.01%	2763
2013 Q3	$5.02M	Buy	1,636,950 +37,765	+2%	+$120K	﹤0.01%	2729
2013 Q2	$5.11M	Buy	+1,599,185	New	+$5.12M	﹤0.01%	2687